Hereditary motor and sensory neuropathies: a biological perspective

Mutations in genes expressed in Schwann cells and the axons they ensheath cause the hereditary motor and sensory neuropathies known as Charcot-Marie-Tooth (CMT) disease. At present, mutations in ten different genes have been identified, chromosomal localisation of many other distinct inherited neuropathies has been mapped, and new genetic causes for inherited neuropathies continue to be discovered. How to keep track of these mutations is a challenge for any neurologist, partly because the mutations are commonly presented as an expanding list to be memorised without a biological context of how the encoded proteins behave in the cell. A further challenge for investigators studying diseases of the peripheral nervous system is the increasing complexity of myelination, axonal function, and interactions between Schwann cells and axons. To address these concerns, we present the mutated genes causing these inherited neuropathies in the context of the cell biology of the Schwann cell and axon, and we begin to develop a model of how the various genes may interact in the pathogenesis of CMT disease.

[1]  J. Julien,et al.  Delayed Maturation of Regenerating Myelinated Axons in Mice Lacking Neurofilaments , 1997, Experimental Neurology.

[2]  Steven H Y Hsieh,et al.  Regional modulation of neurofilament organization by myelination in normal axons , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[3]  M. Koenig,et al.  The gene encoding gigaxonin, a new member of the cytoskeletal BTB/kelch repeat family, is mutated in giant axonal neuropathy , 2000, Nature Genetics.

[4]  F. Gabreëls,et al.  Allelic heterogeneity in hereditary motor and sensory neuropathy type la (Charcot‐Marie‐Tooth disease type 1a) , 1993, Neurology.

[5]  F. Baas,et al.  A frame shift mutation in the PMP22 gene in hereditary neuropathy with liability to pressure palsies , 1994, Nature Genetics.

[6]  B. Trapp,et al.  Role of myelin Po protein as a homophilic adhesion molecule , 1990, Nature.

[7]  J. Lupski,et al.  Clinical Phenotypes of Different MPZ (P0) Mutations May Include Charcot–Marie–Tooth Type 1B, Dejerine–Sottas, and Congenital Hypomyelination , 1996, Neuron.

[8]  S. Scherer,et al.  On the molecular architecture of myelinated fibers , 2000, Histochemistry and Cell Biology.

[9]  P. Dyck,et al.  Lower motor and primary sensory neuron diseases with peroneal muscular atrophy. II. Neurologic, genetic, and electrophysiologic findings in various neuronal degenerations. , 1968, Archives of neurology.

[10]  J. Lupski,et al.  Myelin protein zero (MPZ) gene mutations in nonduplication type 1 Charcot‐Marie‐Tooth disease , 1996, Human mutation.

[11]  C. van Broeckhoven,et al.  Further evidence that neurofilament light chain gene mutations can cause Charcot‐Marie‐Tooth disease type 2E , 2001, Annals of neurology.

[12]  P. Dyck,et al.  Lower motor and primary sensory neuron diseases with peroneal muscular atrophy. I. Neurologic, genetic, and electrophysiologic findings in hereditary polyneuropathies. , 1968, Archives of neurology.

[13]  M. Watson,et al.  EGR2 Mutations in Inherited Neuropathies Dominant-Negatively Inhibit Myelin Gene Expression , 2001, Neuron.

[14]  E. Dupin,et al.  Cell lineage analysis in neural crest ontogeny. , 1993, Journal of neurobiology.

[15]  C. Disteche,et al.  DNA deletion associated with hereditary neuropathy with liability to pressure palsies , 1993, Cell.

[16]  D. Sherman,et al.  Two PDZ Domain Proteins Encoded by the Murine Periaxin Gene Are the Result of Alternative Intron Retention and Are Differentially Targeted in Schwann Cells* , 1998, The Journal of Biological Chemistry.

[17]  L. Kalaydjieva,et al.  A novel locus for autosomal recessive peripheral neuropathy in the EGR2 region on 10q23. , 2000, American journal of human genetics.

[18]  A. Aguayo,et al.  Myelination of mouse axons by Schwann cells transplanted from normal and abnormal human nerves , 1977, Nature.

[19]  D. Sherman,et al.  A Tripartite Nuclear Localization Signal in the PDZ-domain Protein L-periaxin* , 2000, The Journal of Biological Chemistry.

[20]  Peter J. Brophy,et al.  Periaxin, a novel protein of myelinating schwann cells with a possible role in axonal ensheathment , 1994, Neuron.

[21]  K. Nave,et al.  A Transgenic Rat Model of Charcot-Marie-Tooth Disease , 1996, Neuron.

[22]  O. Combarros,et al.  Charcot-Marie-Tooth disease type 1A with 17p duplication in infancy and early childhood , 1998, Neurology.

[23]  S. Botti,et al.  Cranial nerve involvement in CMT disease type 1 due to early growth response 2 gene mutation , 2000, Neurology.

[24]  V. Ionasescu,et al.  Screening of dominantly inherited Charcot–Marie–Tooth neuropathies , 1993, Muscle & nerve.

[25]  J. Mendell,et al.  Effects of PMP22 duplication and deletions on the axonal cytoskeleton , 1999, Annals of neurology.

[26]  T. Uchida,et al.  Isolation of 10 Differentially Expressed cDNAs in Differentiated Neuro2a Cells Induced Through Controlled Expression of the GD3 Synthase Gene , 1999, Journal of Neurochemistry.

[27]  E. Bellone,et al.  A Novel Mutation (D305V) in the early growth response 2 gene is associated with severe Charcot‐Marie‐Tooth type 1 disease , 1999 .

[28]  W. Bradley,et al.  The peroneal muscular atrophy syndrome Clinical, genetic, electrophysiological and nerve biopsy studies part 3. Clinical, electrophysiological and pathological correlations , 1977, Journal of the Neurological Sciences.

[29]  Q. Yan,et al.  In vivo neurotrophic effects of GDNF on neonatal and adult facial motor neurons , 1995, Nature.

[30]  W. Hendrickson,et al.  Crystal Structure of the Extracellular Domain from P0, the Major Structural Protein of Peripheral Nerve Myelin , 1996, Neuron.

[31]  C. Lacroix,et al.  The Roussy‐Lévy family: From the original description to the gene , 1999, Annals of neurology.

[32]  I. Marín,et al.  The gene encoding ganglioside-induced differentiation-associated protein 1 is mutated in axonal Charcot-Marie-Tooth type 4A disease , 2002, Nature Genetics.

[33]  Sylvie M. de Waegh,et al.  Altered slow axonal transport and regeneration in a myelin-deficient mutant mouse: the trembler as an in vivo model for Schwann cell-axon interactions , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[34]  D. Sherman,et al.  Periaxin expression in myelinating Schwann cells: modulation by axon-glial interactions and polarized localization during development. , 1995, Development.

[35]  J. Kamholz,et al.  Axons regulate Schwann cell expression of the POU transcription factor SCIP , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[36]  A. Windebank,et al.  Congenital hypomyelination due to myelin protein zero Q215X mutation , 1999, Annals of neurology.

[37]  J. Mandel,et al.  The myotubularin family: from genetic disease to phosphoinositide metabolism. , 2001, Trends in genetics : TIG.

[38]  A. Aguzzi,et al.  Distal axonopathy in peripheral nerves of PMP22-mutant mice. , 1999, Brain : a journal of neurology.

[39]  J. Lupski,et al.  Dejerine–Sottas syndrome associated with point mutation in the peripheral myelin protein 22 (PMP22) gene , 1993, Nature Genetics.

[40]  M. Rosenfeld,et al.  Tst-1/Oct-6/SCIP regulates a unique step in peripheral myelination and is required for normal respiration. , 1996, Genes & development.

[41]  Virginia M. Y. Lee,et al.  Formation of Compact Myelin Is Required for Maturation of the Axonal Cytoskeleton , 1999, The Journal of Neuroscience.

[42]  D. Sherman,et al.  Specific Disruption of a Schwann Cell Dystrophin-Related Protein Complex in a Demyelinating Neuropathy , 2001, Neuron.

[43]  J. Lupski,et al.  Charcot-Marie-Tooth disease type 1A. Association with a spontaneous point mutation in the PMP22 gene. , 1993, The New England journal of medicine.

[44]  K. Offord,et al.  The nature of myelinated nerve fiber degeneration in dominantly inherited hypertrophic neuropathy. , 1974, Mayo Clinic proceedings.

[45]  R. Axel,et al.  Isolation and sequence of a cDNA encoding the major structural protein of peripheral myelin , 1985, Cell.

[46]  A. Mégarbané,et al.  A mutation in periaxin is responsible for CMT4F, an autosomal recessive form of Charcot-Marie-Tooth disease. , 2001, Human molecular genetics.

[47]  S M Leber,et al.  Periaxin mutations cause recessive Dejerine-Sottas neuropathy. , 2001, American journal of human genetics.

[48]  G. Sobue,et al.  A novel missense mutation in the early growth response 2 gene associated with late-onset Charcot–Marie–Tooth disease type 1 , 2001, Journal of the Neurological Sciences.

[49]  M. Filbin,et al.  The cytoplasmic domain of the myelin P0 protein influences the adhesive interactions of its extracellular domain , 1994, The Journal of cell biology.

[50]  A. Asbury,et al.  Giant axonal neuropathy — A unique case with segmental neurofilamentous masses , 2004, Acta Neuropathologica.

[51]  J. Lupski,et al.  Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies , 1998, Nature Genetics.

[52]  P K Thomas,et al.  The clinical features of hereditary motor and sensory neuropathy types I and II. , 1980, Brain : a journal of neurology.

[53]  M. Pericak-Vance,et al.  Hereditary motor and sensory neuropathy, X‐linked , 1987, Neurology.

[54]  R. G. Harrison Neuroblast versus sheath cell in the development of peripheral nerves , 1924 .

[55]  K. Fischbeck,et al.  Connexin32‐null mice develop demyelinating peripheral neuropathy , 1998, Glia.

[56]  Ram K. Sihag,et al.  Local Control of Neurofilament Accumulation during Radial Growth of Myelinating Axons in Vivo , 2000, The Journal of cell biology.

[57]  V. Ionasescu,et al.  Dejerine-Sottas disease with de novo dominant point mutation of the PMP22 gene , 1995, Neurology.

[58]  S. Scherer,et al.  The Transcription Factors SCIP and Krox-20 Mark Distinct Stages and Cell Fates in Schwann Cell Differentiation , 1996, Molecular and Cellular Neuroscience.

[59]  J. Ott,et al.  Evidence for linkage of Charcot-Marie-Tooth neuropathy to the Duffy locus on chromosome 1. , 1982, American journal of human genetics.

[60]  M. Shy,et al.  Absence of P0 leads to the dysregulation of myelin gene expression and myelin morphogenesis , 2000, Journal of neuroscience research.

[61]  S. Scherer The biology and pathobiology of Schwann cells. , 1997, Current opinion in neurology.

[62]  W. Bradley,et al.  Childhood giant axonal neuropathy case report and review of the literature , 1987, Journal of the Neurological Sciences.

[63]  S. Scherer Molecular specializations at nodes and paranodes in peripheral nerve , 1996, Microscopy research and technique.

[64]  W. Brown,et al.  X-linked dominant hereditary motor and sensory neuropathy. , 1990, Brain : a journal of neurology.

[65]  C. van Broeckhoven,et al.  The Thr124Met mutation in the peripheral myelin protein zero (MPZ) gene is associated with a clinically distinct Charcot-Marie-Tooth phenotype. , 1999, Brain : a journal of neurology.

[66]  Aldo Quattrone,et al.  Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2 , 2000, Nature Genetics.

[67]  O. Evgrafov,et al.  A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene. , 2000, American journal of human genetics.

[68]  J. Griffin,et al.  Altered neurofilament phosphorylation and beta tubulin isotypes in Charcot‐Marie‐Tooth disease type 1 , 1994, Neurology.

[69]  W. Bradley,et al.  The peroneal muscular atrophy syndrome: clinical, genetic, electrophysiological and nerve biopsy studies. I. Clinical, genetic and electrophysiological findings and classification. , 1978, Journal de genetique humaine.

[70]  T. Crawford,et al.  Localization of the giant axonal neuropathy gene to chromosome 16q24 , 1998, Annals of neurology.

[71]  N. Wood,et al.  Dejerine‐sottas neuropathy and PMP22 point mutations: A new base pair substitution and a possible “hot spot” on Ser72 , 1998, Annals of neurology.

[72]  S. Scherer,et al.  Charcot-Marie-Tooth disease type 1: molecular pathogenesis to gene therapy. , 2000, Brain : a journal of neurology.

[73]  R. Oppenheim,et al.  Developing motor neurons rescued from programmed and axotomy-induced cell death by GDNF , 1995, Nature.

[74]  C. van Broeckhoven,et al.  Mutations in the peripheral myelin genes and associated genes in inherited peripheral neuropathies , 1999, Human mutation.

[75]  N. Hirokawa,et al.  Charcot-Marie-Tooth Disease Type 2A Caused by Mutation in a Microtubule Motor KIF1Bβ , 2001, Cell.

[76]  F. Gabreëls,et al.  Early morphological features in dominantly inherited demyelinating motor and sensory neuropathy (HMSN type I) , 1992, Journal of the Neurological Sciences.

[77]  T. Crawford,et al.  Neurofilament distribution and organization in the myelinated axons of the peripheral nervous system , 1994, Brain Research.

[78]  F. Muntoni,et al.  Hereditary demyelinating neuropathy of infancy. A genetically complex syndrome. , 1997, Brain : a journal of neurology.

[79]  R. Mirsky,et al.  Schwann cell development, differentiation and myelination , 1996, Current Opinion in Neurobiology.

[80]  M. Schachner,et al.  Mouse P 0 gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons , 1992, Cell.

[81]  F. Baas,et al.  Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a) , 1991, Neuromuscular Disorders.

[82]  Jean-Pierre Julien,et al.  Electrophysiological properties of axons in mice lacking neurofilament subunit genes: disparity between conduction velocity and axon diameter in absence of NF-H , 2000, Brain Research.

[83]  Aravinda Chakravarti,et al.  DNA duplication associated with Charcot-Marie-Tooth disease type 1A , 1991, Cell.

[84]  V. Timmerman,et al.  Charcot‐Marie‐Tooth Neuropathy Type 2 and P0 Point Mutations: Two Novel Amino Acid Substitutions (Asp61Gly; Tyr119Cys) and a Possible “Hotspot” on Thr124Met , 2000, Brain pathology.

[85]  J. Riggs,et al.  Evolution of nerve conduction abnormalities in children with dominant hypertrophic neuropathy of the charcot‐marie‐tooth type , 1983, Muscle & nerve.

[86]  M. Shy,et al.  Mutations in the cytoplasmic domain of P0 reveal a role for PKC-mediated phosphorylation in adhesion and myelination , 2001, The Journal of cell biology.

[87]  F. Muntoni,et al.  Charcot-Marie-Tooth disease type 2 associated with mutation of the myelin protein zero gene , 1998, Neurology.

[88]  A. Quattrone,et al.  Autosomal Recessive Hereditary Motor and Sensory Neuropathy with Focally Folded Myelin Sheaths (CMT4B) , 1999, Annals of the New York Academy of Sciences.

[89]  J. Gilbert,et al.  Ganglioside-induced differentiation-associated protein-1 is mutant in Charcot-Marie-Tooth disease type 4A/8q21 , 2002, Nature Genetics.

[90]  S. Schneider-Maunoury,et al.  Krox-20 controls myelination in the peripheral nervous system , 1994, Nature.

[91]  U. Suter,et al.  Heterozygous Peripheral Myelin Protein 22-Deficient Mice Are Affected by a Progressive Demyelinating Tomaculous Neuropathy , 1997, The Journal of Neuroscience.

[92]  S. Hinderer,et al.  Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A. , 2000, Brain : a journal of neurology.

[93]  K. Campbell,et al.  Dystroglycan is a binding protein of laminin and merosin in peripheral nerve , 1994, FEBS letters.

[94]  A. Harding,et al.  The phenotypic manifestations of chromosome 17p11.2 duplication. , 1997, Brain : a journal of neurology.

[95]  M. Filbin,et al.  Dominant-negative effect on adhesion by myelin Po protein truncated in its cytoplasmic domain , 1996, The Journal of cell biology.

[96]  C. van Broeckhoven,et al.  Identification of a 5' splice site mutation in the PMP-22 gene in autosomal dominant Charcot-Marie-Tooth disease type 1. , 1994, Human molecular genetics.

[97]  J. Lupski,et al.  Novel missense mutation in the early growth response 2 gene associated with Dejerine–Sottas syndrome phenotype , 1999, Neurology.

[98]  R. Lovelace,et al.  CLINICAL AND ELECTRODIAGNOSTIC FEATURES OF CHARCOT‐MARIE‐TOOTH SYNDROME , 1978, Acta neurologica Scandinavica. Supplementum.

[99]  A. Brice,et al.  Ultrastructural PMP22 expression in inherited demyelinating neuropathies , 1996, Annals of neurology.

[100]  A. Aguzzi,et al.  Impaired Differentiation of Schwann Cells in Transgenic Mice with Increased PMP22 Gene Dosage , 1996, The Journal of Neuroscience.

[101]  A. Harding,et al.  Genetic aspects of hereditary motor and sensory neuropathy (types I and II) , 1980, Journal of medical genetics.

[102]  K. Willecke,et al.  Structural Abnormalities and Deficient Maintenance of Peripheral Nerve Myelin in Mice Lacking the Gap Junction Protein Connexin 32 , 1997, The Journal of Neuroscience.

[103]  M. Pericak-Vance,et al.  Linkage of Charcot-Marie-Tooth neuropathy type 1a to chromosome 17 , 1989, Experimental Neurology.

[104]  F. Buchthal,et al.  Peroneal muscular atrophy (PMA) and related disorders. I. Clinical manifestations as related to biopsy findings, nerve conduction and electromyography. , 1977, Brain : a journal of neurology.